Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Cervical Cancer, June 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 241 articles:
HTML format


 

Single Articles

  1. SHI Z, Wu D, Xu H, Yang J, et al
    CSNK2A1-mediated phosphorylation of HMGA2 modulates cisplatin resistance in cervical cancer.
    FEBS Open Bio. 2021 Jun 11. doi: 10.1002/2211-5463.13228.
    PubMed    
    Abstract available

  2. KRAKAUER EL, Kane K, Kwete X, Afshan G, et al
    Augmented Package of Palliative Care for Women With Cervical Cancer: Responding to Refractory Suffering.
    JCO Glob Oncol. 2021;7:886-895.
    PubMed    
    Abstract available

  3. KRAKAUER EL, Kane K, Kwete X, Afshan G, et al
    Essential Package of Palliative Care for Women With Cervical Cancer: Responding to the Suffering of a Highly Vulnerable Population.
    JCO Glob Oncol. 2021;7:873-885.
    PubMed    
    Abstract available

  4. KRAKAUER EL, Kwete X, Kane K, Afshan G, et al
    Cervical Cancer-Associated Suffering: Estimating the Palliative Care Needs of a Highly Vulnerable Population.
    JCO Glob Oncol. 2021;7:862-872.
    PubMed    
    Abstract available

  5. PARK SJ, Mun J, Lee S, Luo Y, et al
    Laterally Extended Endopelvic Resection Versus Chemo or Targeted Therapy Alone for Pelvic Sidewall Recurrence of Cervical Cancer.
    Front Oncol. 2021;11:683441.
    PubMed    
    Abstract available

  6. WANG H, Wang R, Liu J, Zhang J, et al
    Tree-based exploration of the optimization objectives for automatic cervical cancer IMRT treatment planning.
    Br J Radiol. 2021 Jun 11:20210214. doi: 10.1259/bjr.20210214.
    PubMed    
    Abstract available

  7. PANDEY P, Khan F, Farhan M, Jafri A, et al
    Elucidation of Rutin role in inducing caspase dependent apoptosis via HPV-E6 and E7 downregulation in cervical cancer HeLa cells.
    Biosci Rep. 2021 Jun 10. pii: 228976. doi: 10.1042/BSR20210670.
    PubMed    
    Abstract available

  8. YAMAZAKI H, Mitamura T, Ihira K, Endo D, et al
    The difficulty to diagnose cervical cancer developing in the perinatal period with the first-trimester cytology: A retrospective study.
    J Obstet Gynaecol Res. 2021 Jun 9. doi: 10.1111/jog.14882.
    PubMed    
    Abstract available

  9. ZHU J, Kamara S, Wang Q, Guo Y, et al
    Novel Affibody Molecules Targeting the HPV16 E6 Oncoprotein Inhibited the Proliferation of Cervical Cancer Cells.
    Front Cell Dev Biol. 2021;9:677867.
    PubMed    
    Abstract available

  10. XU F, Shen J, Xu S
    Multi-Omics Data Analyses Construct a Six Immune-Related Genes Prognostic Model for Cervical Cancer in Tumor Microenvironment.
    Front Genet. 2021;12:663617.
    PubMed    
    Abstract available

  11. AHANGARI S, Hansen NL, Olin AB, Nottrup TJ, et al
    Toward PET/MRI as one-stop shop for radiotherapy planning in cervical cancer patients.
    Acta Oncol. 2021 Jun 9:1-9. doi: 10.1080/0284186X.2021.1936164.
    PubMed    
    Abstract available

  12. TSUJI K, Shimada M, Takahashi F, Tokunaga H, et al
    Clinico-pathological characteristics of patients with stage IB1-IB2 (FIGO 2018) uterine cervical cancer: a nationwide study in Japan.
    Int J Clin Oncol. 2021 Jun 9. pii: 10.1007/s10147-021-01938.
    PubMed    
    Abstract available

  13. PAEK J, Lim PC
    The early surgical period in robotic radical hysterectomy is related to the recurrence after surgery in stage IB cervical cancer.
    Int J Med Sci. 2021;18:2697-2704.
    PubMed    
    Abstract available

  14. MOHANTY S, Gurram L, Chopra S, Mahantshetty U, et al
    Cervical Cancer Treatment in HIV-Positive Patients: A Survey of Treatment Practices in India.
    JCO Glob Oncol. 2021;7:843-848.
    PubMed    
    Abstract available


  15. Retraction: HOTAIR contributes to cell proliferation and metastasis of cervical cancer via targeting miR-23b/MAPK1 axis.
    Biosci Rep. 2021;41.
    PubMed    



  16. Retraction: Study of the biological function of LncRNA LUCAT1 on cervical cancer cells by targeting miR-199b-5p.
    Biosci Rep. 2021;41.
    PubMed    


  17. SHYLASREE TS, Ranade R, Kattepur AK, Kaur S, et al
    Quality of life in long term survivors of cervical cancer: A cross sectional study.
    Indian J Cancer. 2021;58:171-178.
    PubMed    
    Abstract available

  18. MUKHOPADHYAY M
    Organoid systems to recapitulate cervical cancer.
    Nat Methods. 2021;18:596.
    PubMed    


  19. TRUJILLO-CIRILO L, Torres-Corioriles EI, Rangel-Corona R, Corona-Ortega MT, et al
    Evidence that the viral oncoproteins E6 and E7 of HPV induce the expression of a functional IL-2R on cervical cancer cells.
    Cytokine. 2021 Jun 4:155592. doi: 10.1016/j.cyto.2021.155592.
    PubMed    
    Abstract available

  20. LESINSKA-SAWICKA M
    A cross-sectional study to assess knowledge of women about cervical cancer: an urban and rural comparison.
    Environ Health Prev Med. 2021;26:64.
    PubMed    
    Abstract available

  21. D'ALTON P, Craddock F, Bergin N, Lynch J, et al
    Exploring the lived experience of partners of women impacted by cervical cancer and the CervicalCheck screening failure in Ireland.
    Psychooncology. 2021 Jun 7. doi: 10.1002/pon.5742.
    PubMed    
    Abstract available

  22. EMRU K, Abebaw TA, Abera A
    Role of awareness on cervical cancer screening uptake among HIV positive women in Addis Ababa, Ethiopia: A cross-sectional study.
    Womens Health (Lond). 2021;17:17455065211017041.
    PubMed    
    Abstract available

  23. GHEBRENDRIAS S, Pfeil S, Crouthamel B, Chalmiers M, et al
    An Examination of Misconceptions and Their Impact on Cervical Cancer Prevention Practices among Sub-Saharan African and Middle Eastern Refugees.
    Health Equity. 2021;5:382-389.
    PubMed    
    Abstract available

  24. BHATLA N, Meena J, Kumari S, Banerjee D, et al
    Cervical Cancer Prevention Efforts in India.
    Indian J Gynecol Oncol. 2021;19:41.
    PubMed    
    Abstract available

  25. MUMBA JM, Kasonka L, Owiti OB, Andrew J, et al
    Cervical cancer diagnosis and treatment delays in the developing world: Evidence from a hospital-based study in Zambia.
    Gynecol Oncol Rep. 2021;37:100784.
    PubMed    
    Abstract available

  26. HUANG SK, Ni RX, Wang WJ, Wang D, et al
    Overexpression of LINC00673 Promotes the Proliferation of Cervical Cancer Cells.
    Front Oncol. 2021;11:669739.
    PubMed    
    Abstract available

  27. RAMAKRISHNAN V, de Haydu C, Wilkinson P, Hooda U, et al
    Minnelide, a prodrug, inhibits cervical cancer growth by blocking HPV-induced changes in p53 and pRb.
    Am J Cancer Res. 2021;11:2202-2214.
    PubMed    
    Abstract available

  28. GOU Y, Li F, Huo X, Hao C, et al
    ENO1 monoclonal antibody inhibits invasion, proliferation and clone formation of cervical cancer cells.
    Am J Cancer Res. 2021;11:1946-1961.
    PubMed    
    Abstract available

  29. HU R, Saito AI, Mitsuhashi T, Inoue T, et al
    Radiosensitization using hydrogen peroxide in patients with cervical cancer.
    Mol Clin Oncol. 2021;15:142.
    PubMed    
    Abstract available

  30. HUANG X, Neckenig M, Sun J, Jia D, et al
    Vitamin E succinate exerts anti-tumour effects on human cervical cancer cells via the CD47-SIRPa pathway both in vivo and in vitro.
    J Cancer. 2021;12:3877-3886.
    PubMed    
    Abstract available

  31. CHOI HG, Lee JW, Min CY, Yoo DM, et al
    Analyses of the association between cervical cancer and osteoporosis/osteoporotic fracture: a cross-sectional study using KoGES HEXA data.
    Int J Clin Oncol. 2021 Jun 6. pii: 10.1007/s10147-021-01951.
    PubMed    
    Abstract available

  32. OKYERE J, Duodu PA, Aduse-Poku L, Agbadi P, et al
    Cervical cancer screening prevalence and its correlates in Cameroon: secondary data analysis of the 2018 demographic and health surveys.
    BMC Public Health. 2021;21:1071.
    PubMed    
    Abstract available

  33. HOELZLE CR, Arnoult S, Borem CRM, Ottone M, et al
    microRNA Levels in Cervical Cancer Samples and Relationship with Lesion Grade and HPV Infection.
    Microrna. 2021 Jun 4. pii: MIRNA-EPUB-115982.
    PubMed    
    Abstract available

  34. VON KNEBEL DOEBERITZ M
    [Cervical cancer is preventable today].
    MMW Fortschr Med. 2021;163:51-53.
    PubMed    


  35. NARA K, Taguchi A, Tojima Y, Miyamoto Y, et al
    History of whole pelvis plus para-aortic radiation is a risk factor associated with febrile neutropenia during chemotherapy for recurrent cervical cancer.
    Int J Clin Oncol. 2021 Jun 4. pii: 10.1007/s10147-021-01950.
    PubMed    
    Abstract available

  36. HANLEY SJB
    Towards the elimination of cervical cancer in Japan.
    J Gynecol Oncol. 2021;32:e76.
    PubMed    


  37. LU X, Song X, Hao X, Liu X, et al
    MicroRNA-186-3p attenuates tumorigenesis of cervical cancer by targeting MCM2.
    Oncol Lett. 2021;22:539.
    PubMed    
    Abstract available

  38. CHEN H, Li H, Wang L, Li Y, et al
    A 5-gene DNA methylation signature is a promising prognostic biomarker for early-stage cervical cancer.
    J Obstet Gynaecol. 2021 Jun 4:1-6. doi: 10.1080/01443615.2021.1907563.
    PubMed    
    Abstract available

  39. CROWLEY FJ, O'Cearbhaill RE, Collins DC
    Exploiting somatic alterations as therapeutic targets in advanced and metastatic cervical cancer.
    Cancer Treat Rev. 2021;98:102225.
    PubMed    
    Abstract available

  40. YIMER NB, Mohammed MA, Solomon K, Tadese M, et al
    Cervical cancer screening uptake in Sub-Saharan Africa: a systematic review and meta-analysis.
    Public Health. 2021;195:105-111.
    PubMed    
    Abstract available

  41. HARPER DM, Jimbo M
    Elimination of cervical cancer depends on HPV vaccination and primary HPV screening.
    Lancet Infect Dis. 2021 May 28. pii: S1473-3099(20)30992.
    PubMed    


  42. ZHU K, Bai H, Mu M, Xue Y, et al
    Knockdown of RNF6 inhibits HeLa cervical cancer cell growth via suppression of MAPK/ERK signalling.
    FEBS Open Bio. 2021 Jun 3. doi: 10.1002/2211-5463.13216.
    PubMed    
    Abstract available

  43. ROY R, Mandal S, Chakrabarti J, Saha P, et al
    Downregulation of Hyaluronic acid-CD44 signaling pathway in cervical cancer cell by natural polyphenols Plumbagin, Pongapin and Karanjin.
    Mol Cell Biochem. 2021 Jun 3. pii: 10.1007/s11010-021-04195.
    PubMed    
    Abstract available

  44. ZHONG J, Yuan H, Xu X, Kong S, et al
    [Retracted] MicroRNA195 inhibits cell proliferation, migration and invasion by targeting defective in cullin neddylation 1 domain containing 1 in cervical cancer.
    Int J Mol Med. 2021;48.
    PubMed    
    Abstract available

  45. LAPAILLE L, De Cuypere M, Goffin F, Kakkos A, et al
    [Locally-advanced cervix cancer : multidisciplinary management].
    Rev Med Liege. 2021;76.
    PubMed    
    Abstract available

  46. YAEGASHI Y, Sasaki K
    High-dose-rate brachytherapy using inverse planning optimization with tandem and ovoid applicators for locally advanced cervical cancer: a simulation study.
    Radiol Phys Technol. 2021 Jun 2. pii: 10.1007/s12194-021-00624.
    PubMed    
    Abstract available

  47. ZHU L, Chen R, Jiang C, Xie Q, et al
    Mechanism underlying long noncoding RNA ILF3AS1mediated inhibition of cervical cancer cell proliferation, invasion and migration, and promotion of apoptosis.
    Mol Med Rep. 2021;24.
    PubMed    
    Abstract available

  48. JING H, Ran X, Li Z
    Application of novel tumor-free techniques in laparoscopic radical hysterectomy for early cervical cancer.
    Asian J Surg. 2021 May 30. pii: S1015-9584(21)00258.
    PubMed    


  49. YU L, Sun Y, Su J, Li X, et al
    Bismahanine exerts anticancer effects on human cervical cancer cells by inhibition of growth, migration and invasion via suppression of NF-kB signalling pathway.
    J BUON. 2021;26:644.
    PubMed    
    Abstract available

  50. WU J, Wang N, Jin G, Xue L, et al
    Tormentic acid induces anticancer effects in cisplatin-resistant human cervical cancer cells mediated via cell cycle arrest, ROS production, and targeting mTOR/PI3K/AKT signalling pathway.
    J BUON. 2021;26:643.
    PubMed    
    Abstract available

  51. WU Q, Lu S, Zhang L, Zhao L, et al
    LncRNA HOXA-AS2 Activates the Notch Pathway to Promote Cervical Cancer Cell Proliferation and Migration.
    Reprod Sci. 2021 Jun 2. pii: 10.1007/s43032-021-00626.
    PubMed    
    Abstract available

  52. ABDEL-HAMID NM, Fathy M, Koike C, Yoshida T, et al
    Identification of Chemo and Radio-resistant Sub-population of Stem Cells in Human Cervical Cancer HeLa Cells.
    Cancer Invest. 2021 Jun 2:1-27. doi: 10.1080/07357907.2021.1931875.
    PubMed    
    Abstract available

  53. JI X, Sui L, Song K, Lv T, et al
    PD-L1, PARP1, and MMRs as potential therapeutic biomarkers for neuroendocrine cervical cancer.
    Cancer Med. 2021 Jun 2. doi: 10.1002/cam4.4034.
    PubMed    
    Abstract available

  54. SESHADRI VD
    Brucine promotes apoptosis in cervical cancer cells (ME-180) via suppression of inflammation and cell proliferation by regulating PI3K/AKT/mTOR signaling pathway.
    Environ Toxicol. 2021 Jun 2. doi: 10.1002/tox.23304.
    PubMed    
    Abstract available

  55. AREZZO F, Cormio G, Loizzi V, Cazzato G, et al
    HPV-Negative Cervical Cancer: A Narrative Review.
    Diagnostics (Basel). 2021;11.
    PubMed    
    Abstract available

  56. KAGABU M, Nagasawa T, Tatsuki S, Fukagawa Y, et al
    Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study.
    Medicina (Kaunas). 2021;57.
    PubMed    
    Abstract available

  57. MKRTCHIAN L, Zamulaeva I, Krikunova L, Kiseleva V, et al
    HPV Status and Individual Characteristics of Human Papillomavirus Infection as Predictors for Clinical Outcome of Locally Advanced Cervical Cancer.
    J Pers Med. 2021;11.
    PubMed    
    Abstract available

  58. CHITSIKE L, Duerksen-Hughes PJ
    PPI Modulators of E6 as Potential Targeted Therapeutics for Cervical Cancer: Progress and Challenges in Targeting E6.
    Molecules. 2021;26.
    PubMed    
    Abstract available

  59. LEE JW, Seol KH
    Pretreatment Neutrophil-to-Lymphocyte Ratio Combined with Platelet-to-Lymphocyte Ratio as a Predictor of Survival Outcomes after Definitive Concurrent Chemoradiotherapy for Cervical Cancer.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  60. GRANADOS-LOPEZ AJ, Manzanares-Acuna E, Lopez-Hernandez Y, Castaneda-Delgado JE, et al
    UVB Inhibits Proliferation, Cell Cycle and Induces Apoptosis via p53, E2F1 and Microtubules System in Cervical Cancer Cell Lines.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  61. CIBULA D, Borcinova M, Marnitz S, Jarkovsky J, et al
    Lower-Limb Lymphedema after Sentinel Lymph Node Biopsy in Cervical Cancer Patients.
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  62. CHO O, Kim DW, Cheong JY
    Plasma Exosomal miRNA Levels after Radiotherapy Are Associated with Early Progression and Metastasis of Cervical Cancer: A Pilot Study.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  63. CHEN YH, Wang PH, Chen PN, Yang SF, et al
    Molecular and Cellular Mechanisms of Metformin in Cervical Cancer.
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  64. FENG J, Mansouripour A, Xi Z, Zhang L, et al
    Nujiangexanthone A Inhibits Cervical Cancer Cell Proliferation by Promoting Mitophagy.
    Molecules. 2021;26.
    PubMed    
    Abstract available

  65. LUCIA F, Bourbonne V, Visvikis D, Miranda O, et al
    Radiomics Analysis of 3D Dose Distributions to Predict Toxicity of Radiotherapy for Cervical Cancer.
    J Pers Med. 2021;11.
    PubMed    
    Abstract available

  66. MAVROMMATIS E, Lytsikas-Sarlis P, Troupis T
    Historical pearls of HPV research: from condyloma to cervical cancer.
    Infez Med. 2021;29:278-283.
    PubMed    
    Abstract available

  67. LIU X, Shen X, Zhang J
    TRIP13 exerts a cancer-promoting role in cervical cancer by enhancing Wnt/beta-catenin signaling via ACTN4.
    Environ Toxicol. 2021 Jun 1. doi: 10.1002/tox.23303.
    PubMed    
    Abstract available

  68. DENG C, Zhu K, Liu T, Chen L, et al
    [G6PC knockdown blocks AKT/mTOR pathway to inhibit proliferation, invasion and migration of cervical cancer HeLa cells].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2021;37:520-526.
    PubMed    
    Abstract available

  69. JIN F, Liu Q, Luo H, Zhu R, et al
    Dynamic Changes in Bladder Morphology Over Time in Cervical Cancer Patients.
    Cancer Control. 2021;28:10732748211021082.
    PubMed    
    Abstract available

  70. ZALEWSKA-OTWINOWSKA K, Macios A, Komerska K, Rekosz M, et al
    Interlaboratory agreement in assessment of gynaecological cytology in Cervical Cancer Screening Programme in Poland - a pilot evaluation.
    Pol J Pathol. 2021;72:75-83.
    PubMed    
    Abstract available

  71. RUSSO L, Gui B, Micco M, Panico C, et al
    The role of MRI in cervical cancer > 2 cm (FIGO stage IB2-IIA1) conservatively treated with neoadjuvant chemotherapy followed by conization: a pilot study.
    Radiol Med. 2021 May 31. pii: 10.1007/s11547-021-01377.
    PubMed    
    Abstract available

  72. WANG R, Zhu J, Yang S, Chen X, et al
    Therapeutic effects and prognostic factors of (125)I brachytherapy for pelvic recurrence after early cervical cancer surgery.
    Sci Rep. 2021;11:11356.
    PubMed    
    Abstract available

  73. ESMAT E, Malakzai HA, Haidari M, Haidary AM, et al
    Giant hamartomatous polyp of the uterine cervix with heterologous mesenchymal tissue in a child: a case report.
    J Med Case Rep. 2021;15:279.
    PubMed    
    Abstract available

  74. ARANDA FLORES CE, Gomez Gutierrez G, Ortiz Leon JM, Cruz Rodriguez D, et al
    Self-collected versus clinician-collected cervical samples for the detection of HPV infections by 14-type DNA and 7-type mRNA tests.
    BMC Infect Dis. 2021;21:504.
    PubMed    
    Abstract available

  75. TSUJII K, Ueda Y, Isono M, Miyazaki M, et al
    Dosimetric impact of rotational setup errors in volumetric modulated arc therapy for postoperative cervical cancer.
    J Radiat Res. 2021 May 29. pii: 6288073. doi: 10.1093.
    PubMed    
    Abstract available

  76. JAYAMOHAN S, Kannan M, Moorthy RK, Rajasekaran N, et al
    Corrigendum: Dysregulation of miR-375/AEG-1 Axis by Human Papillomavirus 16/18-E6/E7 Promotes Cellular Proliferation, Migration, and Invasion in Cervical Cancer.
    Front Oncol. 2021;11:694442.
    PubMed    
    Abstract available

  77. ZHANG P, Lin Y, Liu Y
    CLCA2 suppresses the proliferation, migration and invasion of cervical cancer.
    Exp Ther Med. 2021;22:776.
    PubMed    
    Abstract available

  78. GUO R, Liu G, Li C, Liu X, et al
    B7 homolog 6 promotes the progression of cervical cancer.
    Exp Ther Med. 2021;22:774.
    PubMed    
    Abstract available

  79. LIN TT, Li XX, Lv WF, Dong JN, et al
    Diagnostic Value of Combined Intravoxel Incoherent Motion Diffusion-Weighted Magnetic Resonance Imaging with Diffusion Tensor Imaging in Predicting Parametrial Infiltration in Cervical Cancer.
    Contrast Media Mol Imaging. 2021;2021:6651070.
    PubMed    
    Abstract available

  80. IND T
    Overview of fertility sparing treatments for cervical cancer.
    Best Pract Res Clin Obstet Gynaecol. 2021 May 6. pii: S1521-6934(21)00066.
    PubMed    
    Abstract available

  81. UWINS C, Patel H, Prakash Bhandoria G, Butler-Manuel S, et al
    Laparoscopic and Robotic Surgery for Endometrial and Cervical Cancer.
    Clin Oncol (R Coll Radiol). 2021 May 27. pii: S0936-6555(21)00178.
    PubMed    
    Abstract available

  82. GAO Z, Wang Q, Ji M, Guo X, et al
    Exosomal lncRNA UCA1 modulates cervical cancer stem cell self-renewal and differentiation through microRNA-122-5p/SOX2 axis.
    J Transl Med. 2021;19:229.
    PubMed    
    Abstract available

  83. SCHILLER K, Combs SE
    [Effectiveness of sequential vs concurrent chemoradiation or radiation alone in the adjuvant treatment of cervical cancer after hysterectomy].
    Strahlenther Onkol. 2021 May 30. pii: 10.1007/s00066-021-01796.
    PubMed    


  84. QIN F, Pang H, Ma J, Zhao M, et al
    Combined dynamic contrast enhanced MRI parameter with clinical factors predict the survival of concurrent chemo-radiotherapy in patients with 2018 FIGO IIICr stage cervical cancer.
    Eur J Radiol. 2021;141:109787.
    PubMed    
    Abstract available

  85. YANG J, Liu W, Yan Z, Li C, et al
    Polymorphisms in transporter associated with antigen presenting are associated with cervical intraepithelial neoplasia and cervical cancer in a Chinese Han population.
    HLA. 2021 May 29. doi: 10.1111/tan.14333.
    PubMed    
    Abstract available

  86. CANTWELL CJ, Moroney MR, Sheeder J, Guntupalli SR, et al
    Assessing Inequities in Cervical Cancer Quality of Care and Survival Related to Ethnicity and Socioeconomic Factors.
    J Low Genit Tract Dis. 2021 May 28. pii: 00128360-900000000-99342.
    PubMed    
    Abstract available

  87. FOWLER JR, Maani EV, Jack BW, Miller JL, et al
    Cervical pap smears and pandemics: The effect of COVID-19 on screening uptake & opportunities to improve.
    Womens Health (Lond). 2021;17:17455065211017070.
    PubMed    
    Abstract available

  88. TAN CS, Hamzah ND, Ismail ZHF, Jerip AR, et al
    Self-sampling in Human Papillomavirus screening during and post-COVID-19 pandemic.
    Med J Malaysia. 2021;76:298-303.
    PubMed    
    Abstract available

  89. ABDULAZIZ AMA, You X, Liu L, Sun Y, et al
    Management of high-grade squamous intraepithelial lesion patients with positive margin after LEEP conization: A retrospective study.
    Medicine (Baltimore). 2021;100:e26030.
    PubMed    
    Abstract available

  90. LIMBACHIYA D, Kumari R
    Vaginal Closure Before Colpotomy with an Endo-Stapler to Prevent Tumor Spillage in Laparoscopic Surgery for Gynecological Malignancy.
    JSLS. 2021;25.
    PubMed    
    Abstract available

  91. WANG X, Xu J, Gao Y, Qu P, et al
    Necessity for subsequent surgery in women of child-bearing age with positive margins after conization.
    BMC Womens Health. 2021;21:191.
    PubMed    
    Abstract available

  92. NNAJI CA, Kuodi P, Walter FM, Moodley J, et al
    Timeliness of diagnosis of breast and cervical cancers and associated factors in low-income and middle-income countries: a scoping review protocol.
    BMJ Open. 2021;11:e044093.
    PubMed    
    Abstract available

  93. YOUSSEF DTA, Asfour HZ, Genta-Jouve G, Shaala LA, et al
    Magnificines A and B, Antimicrobial Marine Alkaloids Featuring a Tetrahydrooxazolo[3,2-a]azepine-2,5(3H,6H)-dione Backbone from the Red Sea Sponge Negombata magnifica.
    Mar Drugs. 2021;19.
    PubMed    
    Abstract available

  94. TOUNKARA FK, Teguete I, Guedou FA, Talbot D, et al
    Type-specific incidence, persistence and factors associated with human papillomavirus infection among female sex workers in Benin and Mali, West Africa.
    Int J Infect Dis. 2021;106:348-357.
    PubMed    
    Abstract available

  95. FRASER J
    Seizing the Means of Reproduction? Canada, Cancer Screening, and the Colonial History of the Cytopipette.
    Can Bull Med Hist. 2021;38:128-176.
    PubMed    
    Abstract available

  96. YAMAGUCHI K, Matsumoto Y, Suzuki R, Nishida H, et al
    Enhanced antitumor activity of combined lipid bubble ultrasound and anticancer drugs in gynecological cervical cancers.
    Cancer Sci. 2021;112:2493-2503.
    PubMed    
    Abstract available

  97. QADERI K, Mirmolaei ST, Geranmayeh M, Sheikh Hasani S, et al
    Iranian women's psychological responses to positive HPV test result: a qualitative study.
    BMC Womens Health. 2021;21:128.
    PubMed    
    Abstract available

  98. HE R, Zhu B, Liu J, Zhang N, et al
    Women's cancers in China: a spatio-temporal epidemiology analysis.
    BMC Womens Health. 2021;21:116.
    PubMed    
    Abstract available

  99. JULIAN MCFARLANE S, Morgan SE, Schlumbrecht M
    Acceptability of a multicomponent, community-based, HPV self-test intervention among Jamaican women.
    Cancer Causes Control. 2021;32:547-554.
    PubMed    
    Abstract available

  100. SHEN Y, Xia J, Li H, Xu Y, et al
    Human papillomavirus infection rate, distribution characteristics, and risk of age in pre- and postmenopausal women.
    BMC Womens Health. 2021;21:80.
    PubMed    
    Abstract available

  101. ZHANG W, Shan H, Jiang K, Huang W, et al
    A novel intracellular nanobody against HPV16 E6 oncoprotein.
    Clin Immunol. 2021;225:108684.
    PubMed    
    Abstract available

  102. BUICK C, Murphy KJ, Howell D, Metcalfe K, et al
    Understanding the role of oncogenic human papillomavirus (HPV) status on adherence behaviors among women with abnormal cervical cytology.
    BMC Womens Health. 2021;21:29.
    PubMed    
    Abstract available

  103. BOOTH BB, Petersen LK, Blaakaer J, Johansen T, et al
    Can the dynamic spectral imaging (DSI) color map improve colposcopy examination for precancerous cervical lesions? A prospective evaluation of the DSI color map in a multi-biopsy clinical setting.
    BMC Womens Health. 2021;21:21.
    PubMed    
    Abstract available

  104. KAMATH MULKI A, Withers M
    Human Papilloma Virus self-sampling performance in low- and middle-income countries.
    BMC Womens Health. 2021;21:12.
    PubMed    
    Abstract available

  105. CARRILLO T, Montealegre JR, Bracamontes CG, Scheurer ME, et al
    Predictors of timely diagnostic follow-up after an abnormal Pap test among Hispanic women seeking care in El Paso, Texas.
    BMC Womens Health. 2021;21:11.
    PubMed    
    Abstract available

  106. KOHN JR, Katebi Kashi P, Acosta-Torres S, Beavis AL, et al
    Fertility-sparing Surgery for Patients with Cervical, Endometrial, and Ovarian Cancers.
    J Minim Invasive Gynecol. 2021;28:392-402.
    PubMed    
    Abstract available

  107. ROSSI EC, Tanner E
    Controversies in Sentinel Lymph Node Biopsy for Gynecologic Malignancies.
    J Minim Invasive Gynecol. 2021;28:409-417.
    PubMed    
    Abstract available

  108. BALANCA CC, Salvioni A, Scarlata CM, Michelas M, et al
    PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells.
    JCI Insight. 2021;6.
    PubMed    
    Abstract available

  109. POSSOVER M
    The Modified Schauta-Stoeckel Procedure.
    J Minim Invasive Gynecol. 2021;28:391.
    PubMed    
    Abstract available

  110. EVANS M, Lawson A, Jarin JD, Wilson EE, et al
    Squamous Carcinoma of the Cervix in a 15-Year-Old with Congenital HIV: A Case Report.
    J Pediatr Adolesc Gynecol. 2021;34:234-237.
    PubMed    
    Abstract available

  111. STIRLING CAMERON E, Almukhaini S, Dol J, Aston M, et al
    Access and use of sexual and reproductive health services among resettled refugee and refugee-claimant women in high-income countries: a scoping review protocol.
    JBI Evid Synth. 2021;19:604-613.
    PubMed    
    Abstract available

  112. PONS L, Carballas E, Tapia G
    Primary diffuse large B cell lymphoma of the cervix.
    Med Clin (Barc). 2021;156:530-531.
    PubMed    


  113. GAO N, Wang Q, Tang J, Yao S, et al
    Non-invasive SERS serum detection technology combined with multivariate statistical algorithm for simultaneous screening of cervical cancer and breast cancer.
    Anal Bioanal Chem. 2021 Jun 14. pii: 10.1007/s00216-021-03431.
    PubMed    
    Abstract available

  114. COZZI L, Beriwal S, Kuusela E, Chopra S, et al
    A novel external beam radiotherapy method for cervical cancer patients using virtual straight or bending boost areas; an in-silico feasibility study.
    Radiat Oncol. 2021;16:110.
    PubMed    
    Abstract available

  115. PANJI M, Behmard V, Zare Z, Malekpour M, et al
    Suppressing effects of green tea extract and Epigallocatechin-3-gallate (EGCG) on TGF-beta- induced Epithelial-to-mesenchymal transition via ROS/Smad signaling in human cervical cancer cells.
    Gene. 2021;794:145774.
    PubMed    
    Abstract available

  116. ODIASE O, Noah-Vermillion L, Simone BA, Aridgides PD, et al
    The Incorporation of Immunotherapy and Targeted Therapy Into Chemoradiation for Cervical Cancer: A Focused Review.
    Front Oncol. 2021;11:663749.
    PubMed    
    Abstract available

  117. GOYAL UD, Mehta PP, Samreth S, Gloss J, et al
    Reproducibility of vaginal immobilization balloons in situ overnight for cervical cancer brachytherapy.
    J Contemp Brachytherapy. 2021;13:280-285.
    PubMed    
    Abstract available

  118. KHOJASTE E, Ahmadizadeh C
    Catechin Metabolites along with Curcumin Inhibit Proliferation and Induce Apoptosis in Cervical Cancer Cells by Regulating VEGF Expression In-Vitro.
    Nutr Cancer. 2021 Jun 12:1-10. doi: 10.1080/01635581.2021.1936082.
    PubMed    
    Abstract available

  119. STUART G, D'Lima D
    Perceived barriers and facilitators to attendancefor cervical cancer screening in EU member states:a systematic review and synthesis using the Theoretical Domains Framework.
    Psychol Health. 2021 Jun 13:1-22. doi: 10.1080/08870446.2021.1918690.
    PubMed    
    Abstract available

  120. DONKERS H, Bekkers R, Galaal K
    Systematic Review on Socioeconomic Deprivation and Cervical Cancer: Inequalities in Survival.
    J Health Care Poor Underserved. 2021;32:751-766.
    PubMed    
    Abstract available

  121. SUN L, Liu K, Li X, Zhang Y, et al
    Benefit-finding experiences of cervical cancer survivors in rural Yunnan province, China: A qualitative study.
    Nurs Open. 2021 Jun 13. doi: 10.1002.
    PubMed    
    Abstract available

  122. ALLANSON ER, Schmeler KM
    Cervical Cancer Prevention in Low and Middle Income Countries.
    Clin Obstet Gynecol. 2021 Jun 14. pii: 00003081-900000000-99368.
    PubMed    
    Abstract available

  123. HOU Q, Shen J, Zhou S, Wei J, et al
    Early response to neoadjuvant chemotherapy helps decrease recurrence rate of cervical cancer: a systematic review and meta-analysis.
    Ann Palliat Med. 2021 May 22. pii: apm-20-2004. doi: 10.21037/apm-20-2004.
    PubMed    
    Abstract available

  124. LEI H, Shi J, Teng Y, Song C, et al
    Baicalein modulates the radiosensitivity of cervical cancer cells in vitro via miR-183 and the JAK2/STAT3 signaling pathway.
    Adv Clin Exp Med. 2021 Jun 11. doi: 10.17219/acem/135478.
    PubMed    
    Abstract available

  125. LAKOMY DS, Wu J, Lombe D, Papasavvas E, et al
    Immune correlates of therapy outcomes in women with cervical cancer treated with chemoradiotherapy: A systematic review.
    Cancer Med. 2021 Jun 12. doi: 10.1002/cam4.4017.
    PubMed    
    Abstract available

  126. SANAMI S, Azadegan-Dehkordi F, Rafieian-Kopaei M, Salehi M, et al
    Design of a multi-epitope vaccine against cervical cancer using immunoinformatics approaches.
    Sci Rep. 2021;11:12397.
    PubMed    
    Abstract available

  127. DE NOLA R, Loizzi V, Cicinelli E, Cormio G, et al
    Dynamic crosstalk within the tumor microenvironment of uterine cervical carcinoma: baseline network, iatrogenic alterations, and translational implications.
    Crit Rev Oncol Hematol. 2021;162:103343.
    PubMed    
    Abstract available

  128. ZHAO X, Dong W, Luo G, Xie J, et al
    Silencing of hsa_circ_0009035 Suppresses Cervical Cancer Progression and Enhances Radiosensitivity through MicroRNA 889-3p-Dependent Regulation of HOXB7.
    Mol Cell Biol. 2021;41:e0063120.
    PubMed    
    Abstract available

  129. VAN BEEKHUIZEN HJ, Leusink P, van Kemenade F
    [Elimination of HPV-related cancer: a call for screening and HPV vaccination in The Netherlands].
    Ned Tijdschr Geneeskd. 2021;165.
    PubMed    
    Abstract available

  130. ESCARCEGA-TAME MA, Lopez-Hurtado M, Escobedo-Guerra MR, Reyes-Maldonado E, et al
    Co-infection between genotypes of the human papillomavirus and Chlamydia trachomatis in Mexican women.
    Int J STD AIDS. 2020 Sep 30:956462420947587. doi: 10.1177/0956462420947587.
    PubMed    
    Abstract available

  131. MCBRIDE E, Marlow LAV, Bennett KF, Stearns S, et al
    Exploring reasons for variations in anxiety after testing positive for human papillomavirus with normal cytology: a comparative qualitative study.
    Psychooncology. 2021;30:84-92.
    PubMed    
    Abstract available

  132. XIN Y, Guo W, Yang C, Huang Q, et al
    Photodynamic Effects of Vitamin K3 on Cervical Carcinoma Cells Activating Mitochondrial Apoptosis Pathways.
    Anticancer Agents Med Chem. 2021;21:91-99.
    PubMed    
    Abstract available

  133. WANG H, Zhao J, Yang J, Wan S, et al
    PICT1 is critical for regulating the Rps27a-Mdm2-p53 pathway by microtubule polymerization inhibitor against cervical cancer.
    Biochim Biophys Acta Mol Cell Res. 2021 Jun 21:119084.
    PubMed    
    Abstract available

  134. HIRAOKA S, Nakajima A, Kishi N, Takehana K, et al
    Efficacy of local salvage therapy for recurrent uterine cervical cancer after definitive radiotherapy.
    Int J Clin Oncol. 2021 Jun 24. pii: 10.1007/s10147-021-01974.
    PubMed    
    Abstract available

  135. LUO W
    Predicting Cervical Cancer Outcomes: Statistics, Images, and Machine Learning.
    Front Artif Intell. 2021;4:627369.
    PubMed    
    Abstract available

  136. NIE J, Shao J, Guo SW, Liu X, et al
    The relevance of plasma R-spondin 1 and Slit2 as predictive biomarkers in cervical cancer chemotherapy and radiotherapy.
    Ann Transl Med. 2021;9:837.
    PubMed    
    Abstract available

  137. CHEN J, Zhang N, Liu Y, Han D, et al
    Analysis of Applicator Insertion Related Acute Side Effects for Cervical Cancer Treated With Brachytherapy.
    Front Oncol. 2021;11:677052.
    PubMed    
    Abstract available

  138. LIU L, Wang Y, Geng C, Wang A, et al
    CD155 Promotes the Progression of Cervical Cancer Cells Through AKT/mTOR and NF-kappaB Pathways.
    Front Oncol. 2021;11:655302.
    PubMed    
    Abstract available

  139. JIANG G, Wang X, Zhou Y, Zou C, et al
    TMTP1-Modified, Tumor Microenvironment Responsive Nanoparticles Co-Deliver Cisplatin and Paclitaxel Prodrugs for Effective Cervical Cancer Therapy.
    Int J Nanomedicine. 2021;16:4087-4104.
    PubMed    
    Abstract available

  140. GONG J, Liu H, Bao Z, Bian L, et al
    Relative clinical utility of simultaneous (18)F-fluorodeoxyglucose PET/MRI and PET/CT for preoperative cervical cancer diagnosis.
    J Int Med Res. 2021;49:3000605211019190.
    PubMed    
    Abstract available

  141. WANG D, He J, Dong J, Wu S, et al
    UM-6 induces autophagy and apoptosis via the Hippo-YAP signaling pathway in cervical cancer.
    Cancer Lett. 2021 Jun 20. pii: S0304-3835(21)00244.
    PubMed    
    Abstract available

  142. TOROUS VF, Oliva E
    On the New (Version 9) American Joint Committee on Cancer Tumor, Node, Metastasis Staging for Cervical Cancer-A Commentary.
    Cancer Cytopathol. 2021 Jun 23. doi: 10.1002/cncy.22486.
    PubMed    


  143. WANG L, Zhang S, Cai H, Qi Q, et al
    Inhibition of TLR9 signaling stimulates apoptosis and cell cycle arrest and alleviates angiogenic property in human cervical cancer cells.
    Endocr Metab Immune Disord Drug Targets. 2021 Jun 22. pii: EMIDDT-EPUB-116271.
    PubMed    
    Abstract available

  144. CHEN Y, Gu Y, Gu Y, Wu J, et al
    Long Noncoding RNA LINC00899/miR-944/ESR1 Axis Regulates Cervical Cancer Cell Proliferation, Migration, and Invasion.
    J Interferon Cytokine Res. 2021;41:220-233.
    PubMed    
    Abstract available

  145. ZHDAN VM, Holovanova IA, Vovk OY, Korosh MV, et al
    RELATIONSHIP BETWEEN CERVICAL CANCER AND THE LEVEL OF PREVENTIVE ONCOLOGICAL EXAMINATIONS.
    Wiad Lek. 2021;74:1428-1432.
    PubMed    
    Abstract available

  146. AGBOOLA AMD, Bello OO
    The determinants of knowledge of cervical cancer, attitude towards screening and practice of cervical cancer prevention amongst antenatal attendees in Ibadan, Southwest Nigeria.
    Ecancermedicalscience. 2021;15:1225.
    PubMed    
    Abstract available

  147. MIAO W, Qiuji W, Congkuan S, Yixin L, et al
    Small cell carcinoma as an independent prognostic factor for cervical cancer patients: a population-based analysis.
    Future Oncol. 2021 Jun 22. doi: 10.2217/fon-2020-1081.
    PubMed    
    Abstract available

  148. LEE SA, Baik S, Chung SH
    Functional roles of female sex hormones and their nuclear receptors in cervical cancer.
    Essays Biochem. 2021 Jun 22. pii: 229079. doi: 10.1042/EBC20200175.
    PubMed    
    Abstract available

  149. OUH YT, Park JJ, Kang M, Kim M, et al
    Discrepancy between Cytology and Histology in Cervical Cancer Screening: a Multicenter Retrospective Study (KGOG 1040).
    J Korean Med Sci. 2021;36:e164.
    PubMed    
    Abstract available

  150. DOMENICI L
    Letter to "The application of PAX1 methylation detection and HPV E6/E7 mRNA detection in cervical cancer screening".
    J Obstet Gynaecol Res. 2021 Jun 21. doi: 10.1111/jog.14912.
    PubMed    


  151. TU S, Zhang H, Yang X, Wen W, et al
    Screening of cervical cancer-related hub genes based on comprehensive bioinformatics analysis.
    Cancer Biomark. 2021 Jun 12. pii: CBM203262. doi: 10.3233/CBM-203262.
    PubMed    
    Abstract available

  152. LI W, Song Y, Pan C, Yu J, et al
    Aquaporin-8 is a novel marker for progression of human cervical cancer cells.
    Cancer Biomark. 2021 Jun 18. pii: CBM203251. doi: 10.3233/CBM-203251.
    PubMed    
    Abstract available

  153. MATOBA Y, Nishio H, Sekiguchi K, Uno S, et al
    Meningitis caused by Listeria monocytogenes in a locally advanced cervical cancer patient with pyometra: A case report.
    Gynecol Oncol Rep. 2021;37:100799.
    PubMed    
    Abstract available

  154. WANG J, Jiang L, Ma X, Li T, et al
    Case Report: Solitary Extramedullary Plasmacytoma in the Cervix Misdiagnosed as Cervical Cancer.
    Front Oncol. 2021;11:685070.
    PubMed    
    Abstract available

  155. FAN P, Li X, Feng Y, Cai H, et al
    PD-1 Expression Status on CD8+ Tumour Infiltrating Lymphocytes Associates With Survival in Cervical Cancer.
    Front Oncol. 2021;11:678758.
    PubMed    
    Abstract available

  156. XU C, Ma T, Sun H, Li X, et al
    Markers of Prognosis for Early Stage Cervical Cancer Patients (Stage IB1, IB2) Undergoing Surgical Treatment.
    Front Oncol. 2021;11:659313.
    PubMed    
    Abstract available

  157. HE C, Lu X, Li J, Shen K, et al
    The effect of quercetin on cervical cancer cells as determined by inducing tumor endoplasmic reticulum stress and apoptosis and its mechanism of action.
    Am J Transl Res. 2021;13:5240-5247.
    PubMed    
    Abstract available

  158. SUN R, Chen C, Deng X, Wang F, et al
    IL-11 mediates the Radioresistance of Cervical Cancer Cells via the PI3K/Akt Signaling Pathway.
    J Cancer. 2021;12:4638-4647.
    PubMed    
    Abstract available

  159. FENG J, Gao FY, Li YY, Xiao XY, et al
    Upregulation of LINC01503 promotes cervical cancer progression by targeting the miR-615-3p/CCND1 axis.
    J Cancer. 2021;12:4552-4560.
    PubMed    
    Abstract available

  160. ZHANG J, Lu H, Zhang S, Wang T, et al
    Leveraging Methylation Alterations to Discover Potential Causal Genes Associated With the Survival Risk of Cervical Cancer in TCGA Through a Two-Stage Inference Approach.
    Front Genet. 2021;12:667877.
    PubMed    
    Abstract available

  161. O'DONNELL R, Naik R
    Conservative (non-radical) surgery for stage IB1 cervical cancer.
    Best Pract Res Clin Obstet Gynaecol. 2021 May 24. pii: S1521-6934(21)00069.
    PubMed    
    Abstract available

  162. KYRGIOU M, Bowden SJ, Athanasiou A, Paraskevaidi M, et al
    Morbidity after local excision of the transformation zone for cervical intra-epithelial neoplasia and early cervical cancer.
    Best Pract Res Clin Obstet Gynaecol. 2021 Jun 2. pii: S1521-6934(21)00086.
    PubMed    
    Abstract available

  163. LI J, Ouyang X, Gong X, Li P, et al
    Survival outcomes of minimally invasive surgery for early-stage cervical cancer: A single-center, one surgeon, retrospective study.
    Asian J Surg. 2021 Jun 17. pii: S1015-9584(21)00314.
    PubMed    
    Abstract available

  164. ZIBAKO P, Hlongwa M, Tsikai N, Manyame S, et al
    Mapping evidence on management of cervical cancer in sub-Saharan Africa: scoping review protocol.
    Syst Rev. 2021;10:180.
    PubMed    
    Abstract available

  165. TESFAHUNEI HA, Ghebreyesus MS, Assefa DG, Zeleke ED, et al
    Human papillomavirus self-sampling versus standard clinician-sampling for cervical cancer screening in sub-Saharan Africa: a systematic review and meta-analysis of randomized controlled trials.
    Infect Agent Cancer. 2021;16:43.
    PubMed    
    Abstract available

  166. KAUSHIK M, Chandra Joshi R, Kushwah AS, Gupta MK, et al
    Cytokine gene variants and socio-demographic characteristics as predictors of cervical cancer: A machine learning approach.
    Comput Biol Med. 2021;134:104559.
    PubMed    
    Abstract available

  167. JARY A, Teguete I, Sidibe Y, Kodio A, et al
    Prevalence of cervical HPV infection, sexually transmitted infections and associated antimicrobial resistance in women attending cervical cancer screening in Mali.
    Int J Infect Dis. 2021 Jun 16. pii: S1201-9712(21)00515.
    PubMed    
    Abstract available

  168. HE PY, Hou YH, Yang Y, Li N, et al
    The anticancer effect of extract of medicinal mushroom Sanghuangprous vaninii against human cervical cancer cell via endoplasmic reticulum stress-mitochondrial apoptotic pathway.
    J Ethnopharmacol. 2021;279:114345.
    PubMed    
    Abstract available

  169. LIU Y, Liu L, Mou ZX
    TMEM45A Affects Proliferation, Apoptosis, Epithelial-Mesenchymal Transition, Migration, Invasion and Cisplatin Resistance of HPV-Positive Cervical Cancer Cell Lines.
    Biochem Genet. 2021 Jun 18. pii: 10.1007/s10528-021-10094.
    PubMed    
    Abstract available

  170. MANGANARO L, Lakhman Y, Bharwani N, Gui B, et al
    Correction to: Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018.
    Eur Radiol. 2021 Jun 17. pii: 10.1007/s00330-021-08066.
    PubMed    


  171. LUO T, Xie RZ, Huang YX, Gong XH, et al
    Self-perceived burden and influencing factors in patients with cervical cancer administered with radiotherapy.
    World J Clin Cases. 2021;9:4188-4198.
    PubMed    
    Abstract available

  172. ROUX AN, Kenfack B, Ndjalla A, Sormani J, et al
    Barriers to cervical cancer prevention in rural Cameroon: a qualitative study on healthcare providers' perspective.
    BMJ Open. 2021;11:e043637.
    PubMed    
    Abstract available

  173. MARCUS JZ, Cason P, Downs LS Jr, Einstein MH, et al
    The ASCCP Cervical Cancer Screening Task Force Endorsement and Opinion on the American Cancer Society Updated Cervical Cancer Screening Guidelines.
    J Low Genit Tract Dis. 2021 Jun 15. pii: 00128360-900000000-99338.
    PubMed    
    Abstract available

  174. XIE J, Chen Q, Zhou P, Fan W, et al
    Circular RNA hsa_circ_0000511 Improves Epithelial Mesenchymal Transition of Cervical Cancer by Regulating hsa-mir-296-5p/HMGA1.
    J Immunol Res. 2021;2021:9964538.
    PubMed    
    Abstract available

  175. BONGAERTS THG, Ridder M, Vermeer-Mens JCJ, Plukkel JJ, et al
    Cervical Cancer Screening Among Marginalized Women: A Cross-Sectional Intervention Study.
    Int J Womens Health. 2021;13:549-556.
    PubMed    
    Abstract available

  176. DING D, Lang T, Zou D, Tan J, et al
    Machine learning-based prediction of survival prognosis in cervical cancer.
    BMC Bioinformatics. 2021;22:331.
    PubMed    
    Abstract available

  177. ROSA LMD, Hames ME, Dias M, Miranda GM, et al
    Epidemiological profile of women with gynecological cancer in brachytherapy: a cross-sectional study.
    Rev Bras Enferm. 2021;74:e20200695.
    PubMed    
    Abstract available

  178. KOLODYNSKA A, Streit-Cieckiewicz D, Kot A, Kuliniec I, et al
    Radiation-Induced Recurrent Vesicovaginal Fistula-Treatment with Adjuvant Platelet-Rich Plasma Injection and Martius Flap Placement-Case Report and Review of Literature.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  179. YANG Q, Di Cecco R, McRae S, McLachlin CM, et al
    Implementing HPV Testing for Colposcopy Patients in a Regional Centre.
    J Obstet Gynaecol Can. 2021;43:555-556.
    PubMed    


  180. GRIJALVO S, Ocampo SM, Perales JC, Eritja R, et al
    Preparation of Lipid-Conjugated siRNA Oligonucleotides for Enhanced Gene Inhibition in Mammalian Cells.
    Methods Mol Biol. 2021;2282:119-136.
    PubMed    
    Abstract available

  181. SHIMADA M, Sato S, Shoji T, Nagao S, et al
    Docetaxel and carboplatin chemotherapy for treating patients with stage IVB or recurrent non-squamous cell carcinoma of the uterine cervix: a phase II study.
    Int J Clin Oncol. 2021;26:1314-1321.
    PubMed    
    Abstract available

  182. SUZUKI K, Nagao S, Narita M, Nakazawa H, et al
    Survival impact of adjuvant concurrent chemoradiotherapy after radical hysterectomy in FIGO stage IIIC1 cervical adenocarcinoma.
    Int J Clin Oncol. 2021;26:1322-1329.
    PubMed    
    Abstract available

  183. QADERI K, Mirmolaei ST, Geranmayeh M, Farnam F, et al
    'Does HPV affect my fertility?' Reproductive concerns of HPV-positive women: a qualitative study.
    Reprod Health. 2021;18:72.
    PubMed    
    Abstract available

  184. WANG W, Zhou F
    Cervical HSIL Involving the Endometrium and Adenomyosis: A Case Report and Literature Review.
    J Coll Physicians Surg Pak. 2021;31:337-339.
    PubMed    
    Abstract available

  185. YU D, Qu P, Liu M
    Clinical presentation, treatment, and outcomes associated with vaginal intraepithelial neoplasia: A retrospective study of 118 patients.
    J Obstet Gynaecol Res. 2021;47:1624-1630.
    PubMed    
    Abstract available

  186. LI Y, Liu ZH, Xue P, Chen J, et al
    GRAND: A large-scale dataset and benchmark for cervical intraepithelial Neoplasia grading with fine-grained lesion description.
    Med Image Anal. 2021;70:102006.
    PubMed    
    Abstract available

  187. NAGASE S, Ohta T, Takahashi F, Yaegashi N, et al
    Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual patient report for 2017 and annual treatment report for 2012.
    J Obstet Gynaecol Res. 2021;47:1631-1642.
    PubMed    
    Abstract available

  188. LIN H, Chen H, Wang X, Wang Q, et al
    Dual-path network with synergistic grouping loss and evidence driven risk stratification for whole slide cervical image analysis.
    Med Image Anal. 2021;69:101955.
    PubMed    
    Abstract available

  189. KUMARI S, Bhor VM
    Association of cervicovaginal dysbiosis mediated HPV infection with cervical intraepithelial neoplasia.
    Microb Pathog. 2021;152:104780.
    PubMed    
    Abstract available

  190. WANG J, Staheli JP, Wu A, Kreutz JE, et al
    Detection of 14 High-Risk Human Papillomaviruses Using Digital LAMP Assays on a Self-Digitization Chip.
    Anal Chem. 2021;93:3266-3272.
    PubMed    
    Abstract available

  191. HERNANDEZ-QUIROZ F, Murugesan S, Velazquez-Martinez C, Villalobos-Flores LE, et al
    The vaginal and fecal microbiota of a murine cervical carcinoma model under synergistic effect of 17beta-Estradiol and E7 oncogene expression.
    Microb Pathog. 2021;152:104763.
    PubMed    
    Abstract available

  192. VERGALASOVA I, Ennis RD, Sayan M, Liu B, et al
    The clinical impact of removing rectal gas on high-dose-rate brachytherapy dose distributions for gynecologic cancers.
    J Appl Clin Med Phys. 2021;22:35-41.
    PubMed    
    Abstract available

  193. BAUSSANO I, Sayinzoga F, Tshomo U, Tenet V, et al
    Impact of Human Papillomavirus Vaccination, Rwanda and Bhutan.
    Emerg Infect Dis. 2021;27:1-9.
    PubMed    
    Abstract available

  194. RUTAN MC, Sammon JD, Nguyen DD, Kilbridge KL, et al
    The Relationship Between Health Literacy and Nonrecommended Cancer Screening.
    Am J Prev Med. 2021;60:e69-e72.
    PubMed    
    Abstract available

  195. SCARINCI IC, Li Y, Tucker L, Campos NG, et al
    Given a choice between self-sampling at home for HPV testing and standard of care screening at the clinic, what do African American women choose? Findings from a group randomized controlled trial.
    Prev Med. 2021;142:106358.
    PubMed    
    Abstract available

  196. OHYA A, Kobara H, Miyamoto T, Komatsu M, et al
    Usefulness of the 'cosmos pattern' for differentiating between cervical gastric-type mucin-positive lesions and other benign cervical cystic lesions in magnetic resonance images.
    J Obstet Gynaecol Res. 2021;47:745-756.
    PubMed    
    Abstract available

  197. AYDIN S, Oncu HN, Arici DS
    Diagnostic performance of immediate colposcopy among women with high-risk human papillomavirus (HPV) other than HPV 16/18 and normal cytology.
    J Obstet Gynaecol Res. 2021;47:720-725.
    PubMed    
    Abstract available

  198. ATTIPOE-DORCOO S, Chattopadhyay SK, Verughese J, Ekwueme DU, et al
    Engaging Community Health Workers to Increase Cancer Screening: A Community Guide Systematic Economic Review.
    Am J Prev Med. 2021;60:e189-e197.
    PubMed    
    Abstract available

  199. PESOLA F, Rebolj M, Leeson S, Dunk L, et al
    Introducing human papillomavirus (HPV) primary testing in the age of HPV vaccination: projected impact on colposcopy services in Wales.
    BJOG. 2021;128:1226-1235.
    PubMed    
    Abstract available

  200. CHEN X, Fan B, Jiang L, Nong L, et al
    Predictors of treatment failure after top-hat procedure in squamous intraepithelial lesion.
    J Obstet Gynaecol Res. 2021;47:661-668.
    PubMed    
    Abstract available

  201. LIU Y, McCluggage WG, Darragh TM, Zheng W, et al
    Classifying Anal Intraepithelial Neoplasia 2 Based on LAST Recommendations.
    Am J Clin Pathol. 2021;155:845-852.
    PubMed    
    Abstract available

  202. ESCRIVA-BOULLEY G, Mandrik O, Preau M, Herrero R, et al
    Cognitions and behaviours of general practitioners in France regarding HPV vaccination: A theory-based systematic review.
    Prev Med. 2021;143:106323.
    PubMed    
    Abstract available

  203. DESANA B, Balbo Mussetto A, Macera A, Mariani L, et al
    Rare case of uterine cervix lymphoma with spontaneous regression: Case report.
    J Obstet Gynaecol Res. 2021;47:807-811.
    PubMed    
    Abstract available

  204. DUAN L, Du H, Belinson JL, Liu Z, et al
    Thermocoagulation versus cryotherapy for the treatment of cervical precancers.
    J Obstet Gynaecol Res. 2021;47:279-286.
    PubMed    
    Abstract available

  205. SHIM TN, Harwood CA, Marsh SG, Gotch FM, et al
    Immunogenetics and human papillomavirus (HPV) in male genital lichen sclerosus (MGLSc).
    Int J STD AIDS. 2020 Oct 21:956462420949395. doi: 10.1177/0956462420949395.
    PubMed    
    Abstract available

  206. CHEN H, Zhang X, Wang W, Zhang R, et al
    Effect of an educational intervention on human papillomavirus (HPV) knowledge and attitudes towards HPV vaccines among healthcare workers (HCWs) in Western China.
    Hum Vaccin Immunother. 2021;17:443-450.
    PubMed    
    Abstract available

  207. CHIDO-AMAJUOYI OG, Jackson I, Yu R, Shete S, et al
    Declining awareness of HPV and HPV vaccine within the general US population.
    Hum Vaccin Immunother. 2021;17:420-427.
    PubMed    
    Abstract available

  208. XU L, Ostrbenk Valencak A, Poljak M, Arbyn M, et al
    Evaluation and optimization of the clinical accuracy of Hybribio's 14 High-risk HPV with 16/18 Genotyping assay within the VALGENT-3 framework.
    J Clin Microbiol. 2020 Apr 3. pii: JCM.00234-20. doi: 10.1128/JCM.00234.
    PubMed    
    Abstract available

  209. LIU CZ, Ho N, Nguyen AD, Lehner C, et al
    The risk of preterm delivery and pregnancy outcomes in women with asymptomatic short cervix: a retrospective cohort study.
    J Matern Fetal Neonatal Med. 2021;34:1747-1753.
    PubMed    
    Abstract available

  210. EDVARDSSON H, Wang J, Andrae B, Sparen P, et al
    Nationwide Rereview of Normal Cervical Cytologies before High-Grade Cervical Lesions or before Invasive Cervical Cancer.
    Acta Cytol. 2021 Jun 2:1-8. doi: 10.1159/000515912.
    PubMed    
    Abstract available

  211. PEDRAO PG, de Carvalho AC, Possati-Resende JC, de Paula Cury F, et al
    DNA Recovery Using Ethanol-Based Liquid Medium from FTA Card-Stored Samples for HPV Detection.
    Acta Cytol. 2021;65:264-271.
    PubMed    
    Abstract available

  212. SRIVASTAVA AJ, Contreras JA, Davis M, Markovina ST, et al
    Early posttherapy clearance of human papillomavirus and treatment response in cervical carcinoma.
    Cancer. 2020 Jul 8. doi: 10.1002/cncr.33040.
    PubMed    
    Abstract available

  213. REICH O, Pickel H
    100 years of iodine testing of the cervix: A critical review and implications for the future.
    Eur J Obstet Gynecol Reprod Biol. 2021;261:34-40.
    PubMed    
    Abstract available

  214. MILLS JM, Morgan JR, Dhaliwal A, Perkins RB, et al
    Eligibility for cervical cancer screening exit: Comparison of a national and safety net cohort.
    Gynecol Oncol. 2021 Jun 3. pii: S0090-8258(21)00441.
    PubMed    
    Abstract available

  215. SERT BM, Kristensen GB, Kleppe A, Dorum A, et al
    Long-term oncological outcomes and recurrence patterns in early-stage cervical cancer treated with minimally invasive versus abdominal radical hysterectomy: The Norwegian Radium Hospital experience.
    Gynecol Oncol. 2021 May 31. pii: S0090-8258(21)00434.
    PubMed    
    Abstract available

  216. BRODEUR MN, Dejean R, Beauchemin MC, Samouelian V, et al
    Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
    Gynecol Oncol. 2021 May 28. pii: S0090-8258(21)00429.
    PubMed    
    Abstract available

  217. SONG F, Belinson JL, Yan P, Huang X, et al
    Evaluation of p16(INK4a) immunocytology and human papillomavirus (HPV) genotyping triage after primary HPV cervical cancer screening on self-samples in China.
    Gynecol Oncol. 2021 May 28. pii: S0090-8258(21)00410.
    PubMed    
    Abstract available

  218. BENITO V, Lubrano A, Perez-Regadera JF, Torne A, et al
    Postreatment squamous cell carcinoma antigen as a survival prognostic factor in patients with locally advanced cervical cancer. A Spanish multicenter study. The SEGO Spain-GOG group.
    Gynecol Oncol. 2021 Jun 9. pii: S0090-8258(21)00485.
    PubMed    
    Abstract available

  219. RONSINI C, Anchora LP, Restaino S, Fedele C, et al
    The role of semiquantitative evaluation of lympho-vascular space invasion in early stage cervical cancer patients.
    Gynecol Oncol. 2021 Jun 9. pii: S0090-8258(21)00482.
    PubMed    
    Abstract available

  220. ZHANG G, Zhang Y, He F, Wu H, et al
    Preoperative controlling nutritional status (CONUT) score is a prognostic factor for early-stage cervical cancer patients with high-risk factors.
    Gynecol Oncol. 2021 Jun 17. pii: S0090-8258(21)00492.
    PubMed    
    Abstract available

  221. BONDE J, Floore A, Ejegod D, Vink FJ, et al
    Methylation markers FAM19A4 and miR124-2 as triage strategy for primary HPV screen positive women; A large European multi-center study.
    Int J Cancer. 2020 Sep 30. doi: 10.1002/ijc.33320.
    PubMed    
    Abstract available

  222. EL-ZEIN M, Gotlieb W, Gilbert L, Hemmings R, et al
    Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
    Int J Cancer. 2021;148:492-501.
    PubMed    
    Abstract available

  223. INTURRISI F, Lissenberg-Witte BI, Veldhuijzen NJ, Bogaards JA, et al
    Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen-detected cervical precancer.
    Int J Cancer. 2021;148:320-328.
    PubMed    
    Abstract available

  224. VAN SCHALKWYK C, Moodley J, Welte A, Johnson LF, et al
    Modelling the impact of prevention strategies on cervical cancer incidence in South Africa.
    Int J Cancer. 2021 Jun 24. doi: 10.1002/ijc.33716.
    PubMed    
    Abstract available

  225. HUANG HJ, Tung HJ, Yang LY, Chao A, et al
    Role of human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia.
    Int J Cancer. 2021;148:665-672.
    PubMed    
    Abstract available

  226. TIMOTEO-LIAINA I, Khozaim K, Chen YA, Buenconsejo-Lum L, et al
    The rising relative and absolute incidence of uterine cancer in specific populations.
    Int J Gynaecol Obstet. 2020 Feb 29. doi: 10.1002/ijgo.13130.
    PubMed    
    Abstract available

  227. TREJO MJ, Soliman AS, Chen Y, Kalima M, et al
    Effects of HIV infection on metastatic cervical cancer and age at diagnosis among patients in Lusaka, Zambia.
    Int J Gynaecol Obstet. 2021 Jun 14. doi: 10.1002/ijgo.13784.
    PubMed    
    Abstract available

  228. YU Y, Deng T, Gu S
    Minimally invasive surgery and abdominal radical hysterectomy in patients with early-stage cervical cancer: A meta-analysis.
    Int J Gynaecol Obstet. 2021 Jun 24. doi: 10.1002/ijgo.13796.
    PubMed    
    Abstract available

  229. CHILINDA G, Massamba L, Meja S, Ngo C, et al
    Implementing a comprehensive cervical cancer program in Southern Malawi: a 'Medecins Sans Frontieres', Ministry of Health, and College of Medicine of Blantyre Collaborative Project.
    Int J Gynecol Cancer. 2021 Jun 2. pii: ijgc-2021-002743.
    PubMed    


  230. MAHANTSHETTY U, Gurram L, Bushra S, Ghadi Y, et al
    Single application multi-fractionated image guided adaptive High Dose Rate Brachytherapy for Cervical Cancer- Dosimetric & Clinical Outcomes.
    Int J Radiat Oncol Biol Phys. 2021 Jun 16. pii: S0360-3016(21)00732.
    PubMed    
    Abstract available

  231. DATTA NR, Stutz E, Gomez S, Bodis S, et al
    In Reply to Roussakow.
    Int J Radiat Oncol Biol Phys. 2021;109:642-644.
    PubMed    


  232. ROUSSAKOW S
    In Regard to Datta et al.
    Int J Radiat Oncol Biol Phys. 2021;109:641-642.
    PubMed    


  233. SONG X, Shi B, Huang K, Zhang W, et al
    [Retracted] miR133a inhibits cervical cancer growth by targeting EGFR.
    Oncol Rep. 2021;46.
    PubMed    
    Abstract available

  234. CHU J, Gao J, Wang J, Li L, et al
    Mechanism of hydrogen on cervical cancer suppression revealed by highthroughput RNA sequencing.
    Oncol Rep. 2021;46.
    PubMed    
    Abstract available

  235. MARTINS J, Vaz AF, Grion RC, Costa-Paiva L, et al
    Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial.
    BMC Cancer. 2021;21:682.
    PubMed    
    Abstract available

  236. ZHAO J, Cao H, Zhang W, Fan Y, et al
    SOX14 hypermethylation as a tumour biomarker in cervical cancer.
    BMC Cancer. 2021;21:675.
    PubMed    
    Abstract available

  237. RAKHSHANDA S, Dalal K, Chowdhury HA, Mayaboti CA, et al
    Assessing service availability and readiness to manage cervical cancer in Bangladesh.
    BMC Cancer. 2021;21:670.
    PubMed    
    Abstract available

  238. ZOU D, Guo M, Zhou Q
    A clinical study of pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) in preventing neutropenia during concurrent chemoradiotherapy of cervical cancer.
    BMC Cancer. 2021;21:661.
    PubMed    
    Abstract available

  239. BADRE-ESFAHANI S, Petersen LK, Tatari CR, Blaakaer J, et al
    Perceptions of cervical cancer prevention among a group of ethnic minority women in Denmark-A qualitative study.
    PLoS One. 2021;16:e0250816.
    PubMed    
    Abstract available

  240. LIM YJ, Lee HN
    Optimal use of radiotherapy in the definitive treatment of non-bulky IB-IIA cervical cancer: A population-based long-term survival analysis.
    PLoS One. 2021;16:e0253649.
    PubMed    
    Abstract available

  241. KARAWEKPANYAWONG N, Kaewkitikul K, Maneeton B, Maneeton N, et al
    The prevalence of depressive disorder and its association in Thai cervical cancer patients.
    PLoS One. 2021;16:e0252779.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;